These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23000724)

  • 1. Repeated-dose pharmacokinetics of inhaled ciclesonide (CIC-HFA) in Japanese children with bronchial asthma: a phase I study.
    Teramoto T; Matsui E; Fukao T; Sakai K; Yonezawa H; Kato Z; Ohnishi H; Kaneko H; Kondo N; Azuma J; Nishima S
    Allergol Int; 2012 Dec; 61(4):619-24. PubMed ID: 23000724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
    Drollmann A; Nave R; Steinijans VW; Baumgärtner E; Bethke TD
    Clin Pharmacokinet; 2006; 45(7):729-36. PubMed ID: 16802853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
    Nave R; Herzog R; Laurent A; Wingertzahn MA
    Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar.
    Nave R; Gunawardena KA; Zech K; Bethke TD
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):1-7. PubMed ID: 16425964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma.
    Newman S; Salmon A; Nave R; Drollmann A
    Respir Med; 2006 Mar; 100(3):375-84. PubMed ID: 16275052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis.
    Ratner P; Wingertzahn MA; Herzog R; Huang H; Desai SY; Maier G; Nave R
    Pulm Pharmacol Ther; 2011 Aug; 24(4):426-33. PubMed ID: 21501692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer.
    Boss H; Minic P; Nave R
    Clin Med Insights Pediatr; 2010; 4():1-10. PubMed ID: 23761990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
    Richter K; Kanniess F; Biberger C; Nave R; Magnussen H
    J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclesonide--a novel corticosteroid for the management of asthma.
    Chopra D; Bhandari B; Wardhan N
    Curr Clin Pharmacol; 2012 May; 7(2):73-7. PubMed ID: 22283615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
    Nave R; Zech K; Bethke TD
    Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide.
    Böhmer GM; Drollmann A; Gleiter CH; Nave R
    Clin Pharmacokinet; 2008; 47(5):343-9. PubMed ID: 18399715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition and metabolism of inhaled ciclesonide in the human lung.
    Nave R; Watz H; Hoffmann H; Boss H; Magnussen H
    Eur Respir J; 2010 Nov; 36(5):1113-9. PubMed ID: 20351025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
    Kramer S; Rottier BL; Scholten RJ; Boluyt N
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD010352. PubMed ID: 23450613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based covariate pharmacokinetic analysis and lack of cortisol suppression by the new inhaled corticosteroid ciclesonide using a novel cortisol release model.
    Rohatagi S; Krishnaswami S; Pfister M; Sahasranaman S
    Am J Ther; 2005; 12(5):385-97. PubMed ID: 16148423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures.
    Nave R
    Bioanalysis; 2010 Apr; 2(4):807-14. PubMed ID: 21083275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-fine particle inhaled corticosteroids, pharma-cokinetics and systemic activity in children with asthma.
    Wolthers OD
    Pediatr Allergy Immunol; 2016 Feb; 27(1):13-21. PubMed ID: 26360937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclesonide: a review of its use in the management of asthma.
    Deeks ED; Perry CM
    Drugs; 2008; 68(12):1741-70. PubMed ID: 18681495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and pharmacodynamics of ciclesonide.
    Rohatagi S; Arya V; Zech K; Nave R; Hochhaus G; Jensen BK; Barrett JS
    J Clin Pharmacol; 2003 Apr; 43(4):365-78. PubMed ID: 12723457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J; Nave R; Lahu G; Derom E; Derendorf H
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.